Skip to content
2000
image of Clinical Study on the Neuroprotective Effects of Dengzhan Shengmai Capsule on Brain Structure and Cognitive Function in Patients with Vascular Cognitive Impairment

Abstract

Introduction

Vascular Cognitive Impairment (VCI) is a common type of dementia that affects the quality of life and lacks effective treatments. The Dengzhan Shengmian capsule (DZSM), a traditional Chinese medicine, is clinically used to alleviate VCI symptoms, but its therapeutic mechanisms are not fully understood. This study aimed to evaluate the neuroprotective effects of DZSM in VCI patients by investigating its impact on cognitive function and brain structure, thereby providing neuroimaging evidence for its clinical application.

Methods

A randomized, double-masked, 6-month trial was conducted with 100 VCI patients, assigned to either the experimental group receiving DZSM (n = 50) or the placebo group (n = 50). The efficacy of DZSM in VCI patients was assessed through cognitive behavioral assessments and neuroimaging data collected at baseline and after 6 months. A comparison was made across groups to determine cognitive and neural changes associated with the intervention.

Results

Participants receiving DZSM exhibited significant improvements across multiple cognitive domains compared to the placebo, including global cognition (MMSE, 0.019; ADAS-Cog, 0.001), episodic memory (AVLT-N1N5, 0.001), visuospatial ability (CDT, 0.034), and working memory (DST, 0.015). For brain structure, the gray matter volume in the right postcentral and precentral gyrus, bilateral cuneus, left supplementary motor area, superior occipital gyrus, right hippocampus, right thalamus, bilateral lingual gyrus, left precuneus, right inferior frontal gyrus (triangular part), left inferior parietal gyrus, left superior medial frontal gyrus, right superior temporal gyrus, left middle temporal gyrus, and right parahippocampal gyrus increased in the DZSM group (FDR-corrected, 0.05), with no significant changes in white matter microstructure. Moreover, gray matter volume increases positively correlated with improvements in global cognition and visuospatial function.

Discussion

DZSM capsules significantly improved multiple cognitive domains in VCI patients, particularly memory, visuospatial, and executive functions. The observed increases in gray matter volume suggest that DZSM may exert neuroprotective effects through structural brain remodeling, which is closely associated with cognitive enhancement.

Conclusion

This study identifies brain structural abnormalities in VCI patients that correlate with cognitive deficits. DZSM capsule treatment significantly improved cognitive function. While the underlying mechanisms remain to be fully elucidated, these effects may be related to structural changes in the brain.

Clinical Trial Registration Number

The clinical trial registration number is ChiCTR-IPR-16009289.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/car/10.2174/0115672050405934250902112132
2025-10-02
2025-12-14

  • From This Site

    /content/journals/car/10.2174/0115672050405934250902112132
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Rundek T Tolea M Ariko T Fagerli EA Camargo CJ Vascular cognitive impairment (VCI). Neurotherapeutics 2022 19 1 68 88 10.1007/s13311‑021‑01170‑y 34939171
    [Google Scholar]
  2. Han Y Zhou A Li F Wang Q Xu L Jia J Apolipoprotein e ε4 allele is associated with vascular cognitive impairment no dementia in chinese population. J. Neurol. Sci. 2020 409 116606 10.1016/j.jns.2019.116606
    [Google Scholar]
  3. Sha S Tan J Miao Y Zhang Q The role of autophagy in hypoxia-induced neuroinflammation. DNA Cell Biol. 2021 40 6 733 739 10.1089/dna.2020.6186 33989049
    [Google Scholar]
  4. van Dinther M Hooghiemstra AM Bron EE et al Lower cerebral blood flow predicts cognitive decline in patients with vascular cognitive impairment. Alzheimers Dement. 2024 20 1 136 144 10.1002/alz.13408 37491840
    [Google Scholar]
  5. Dintica CS Yaffe K Epidemiology and risk factors for dementia. Psychiatr Clin North Am 2022 45 4 677 689 10.1016/j.psc.2022.07.011 36396272
    [Google Scholar]
  6. Zhang S Zhang J Wei D Dengzhan Shengmai capsules and their active component scutellarin prevent cognitive decline in APP/PS1 mice by accelerating Aβ aggregation and reducing oligomers formation. Biomed. Pharmacother. 2020 121 109682 10.1016/j.biopha.2019.109682 31810113
    [Google Scholar]
  7. Que B Zeng X Ma G Clinical effects of Dengzhan Shengmai Capsules combined with acupuncture on patients with vascular dementia after cerebral infarction. Zhongchengyao 2024 46 05 1529 1532
    [Google Scholar]
  8. Yang XY Wang LQ Li JG Liang N Wang Y Liu JP Chinese herbal medicine Dengzhan Shengmai capsule as adjunctive treatment for ischemic stroke: A systematic review and meta-analysis of randomized clinical trials. Complement. Ther. Med. 2018 36 82 89 10.1016/j.ctim.2017.12.004 29458937
    [Google Scholar]
  9. Shen X Zou S Jin J Liu Y Wu J Qu L Dengzhan Shengmai capsule versus Aspirin in the treatment of carotid atherosclerotic plaque: A single-centre, non-inferiority, prospective, randomised controlled trial. Phytomedicine 2022 106 154408 10.1016/j.phymed.2022.154408 36029646
    [Google Scholar]
  10. You T Wang Y Chen S Dong Q Yu J Cui M Vascular cognitive impairment: Advances in clinical research and management. Chin. Med. J. (Engl.) 2024 137 23 2793 2807 10.1097/CM9.0000000000003220 39048312
    [Google Scholar]
  11. Zatorre R.J Fields R.D Johansen-Berg H Plasticity in gray and white: Neuroimaging changes in brain structure during learning. Nat. Neurosci. 2012 15 4 528 536 10.1038/nn.3045 22426254
    [Google Scholar]
  12. Wan X Zhang S Wang W et al Gray matter abnormalities in Tourette Syndrome: A meta-analysis of voxel-based morphometry studies. Transl. Psychiatry 2021 11 1 287 10.1038/s41398‑021‑01394‑8 33990537
    [Google Scholar]
  13. Ma Y Sun W Effects of Dengzhan Shengmai Capsule combined with butylphthalide soft capsule on oxidative stress indexes and serum Hcy and CRP levels in patients with vascular dementia. Cell. Mol. Biol. 2020 66 6 8 14 10.14715/cmb/2020.66.6.2
    [Google Scholar]
  14. Regier DA Narrow WE Kuhl EA Kupfer DJ The conceptual development of DSM-V. Am. J. Psychiatry 2009 166 6 645 650 10.1176/appi.ajp.2009.09020279 19487400
    [Google Scholar]
  15. Folstein MF Folstein SE McHugh PR Mini-mental state. J Psychiatr Res 1975 12 3 189 198 10.1016/0022‑3956(75)90026‑6 1202204
    [Google Scholar]
  16. Wang H Yu X Li S Chen Y Li H He J The cognitive subscale of Alzheimer’s disease assessment scale, chinese version in staging of Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2004 18 4 231 235 15592136
    [Google Scholar]
  17. Qi-Hao G Yi-Min S Pei-Min Y.U Norm of auditory verbal learning test in the normal aged in china community. Chin. J. Clin. Psychol. 2007
    [Google Scholar]
  18. Rosenberg S.J Ryan J.J Prifitera A Rey auditory-verbal learning test performance of patients with and without memory impairment. J. Clin. Psychol. 1984 40 3 785 787 10.1002/1097‑4679(198405)40:3<785:AID‑JCLP2270400325>3.0.CO;2‑4 6746989
    [Google Scholar]
  19. Tupler L.A Welsh K.A Asare-aboagye Y Dawson D.V Reliability of the rey-osterrieth complex figure in use with memory-impaired patients. J. Clin. Exp. Neuropsychol. 1995 17 4 566 579 10.1080/01688639508405146 7593476
    [Google Scholar]
  20. Ishiai S Sugishita M Ichikawa T Gono S Watabiki S Clock‐drawing test and unilateral spatial neglect. Neurology 1993 43 1_part_1 106 110 10.1212/WNL.43.1_Part_1.106 8423871
    [Google Scholar]
  21. Lynn R Dai X.Y Sex differences on the Chinese standardization sample of the WAIS-R. J. Genet. Psychol. 1993 154 4 459 463 10.1080/00221325.1993.9914744 8176389
    [Google Scholar]
  22. Guo Q.H Hong Z Lv C Application of Stroop color-word test on Chinese elderly patients with mild cognitive impairment and mild Alzheimer’s dementia. Chin J Neuromed 2005 4 7 701 704
    [Google Scholar]
  23. Gordon N.G The trail making test in neuropsychological diagnosis. J. Clin. Psychol. 1972 28 2 167 169 10.1002/1097‑4679(197204)28:2<167:AID‑JCLP2270280212>3.0.CO;2‑X 5019979
    [Google Scholar]
  24. Sheridan L Fitzgerald H Adams K et al Normative Symbol Digit Modalities Test performance in a community-based sample. Arch. Clin. Neuropsychol. 2006 21 1 23 28 10.1016/j.acn.2005.07.003 16139470
    [Google Scholar]
  25. Dou Z Fan Y Chen H Wang X Wei J Li X The efficacy and safety of Shuxuening injection combined with western medicine in vascular dementia treatment: A meta-analysis. Toxicol Adv 2021 3 2 9 10.53388/ATR20210504
    [Google Scholar]
  26. Cummings JL Mini-Mental State Examination. Norms, normals, and numbers. JAMA 1993 269 18 2420 2421 10.1001/jama.1993.03500180112046 8479071
    [Google Scholar]
  27. Rosen WG Mohs RC Davis KL A new rating scale for Alzheimer’s disease. Am. J. Psychiatry 1984 141 11 1356 1364 10.1176/ajp.141.11.1356 6496779
    [Google Scholar]
  28. Magalhes S.S Malloy-Diniz L.F Hamdan A.C Validity convergent and reliability test-retest of the rey auditory verbal learning test. Clin Neuropsychiatry 2012 9 3 129 137
    [Google Scholar]
  29. Shulman K.I Clock-drawing: Is it the ideal cognitive screening test? Int. J. Geriatr. Psychiatry 2000 15 6 548 561 10.1002/1099‑1166(200006)15:6<548:AID‑GPS242>3.0.CO;2‑U 10861923
    [Google Scholar]
  30. Woods D.L Kishiyama M.M Yund E.W et al Improving digit span assessment of short-term verbal memory. J. Clin. Exp. Neuropsychol. 2011 33 1 101 111 10.1080/13803395.2010.493149 20680884
    [Google Scholar]
  31. Lu H Zhang J Liang Y Network topology and machine learning analyses reveal microstructural white matter changes underlying Chinese medicine Dengzhan Shengmai treatment on patients with vascular cognitive impairment. Pharmacol. Res. 2020 156 104773 10.1016/j.phrs.2020.104773 32244028
    [Google Scholar]
  32. Zhang Z Yuan Q Liu Z The cortical organization of writing sequence: Evidence from observing Chinese characters in motion. Brain Struct. Funct. 2021 226 5 1627 1639 10.1007/s00429‑021‑02276‑x 33866405
    [Google Scholar]
  33. Reineberg A.E Banich M.T Functional connectivity at rest is sensitive to individual differences in executive function: A network analysis. Hum. Brain Mapp. 2016 37 8 2959 2975 10.1002/hbm.23219 27167614
    [Google Scholar]
  34. Gorbach T Pudas S Bartrés-Faz D et al Longitudinal association between hippocampus atrophy and episodic‐memory decline in non‐demented APOE ε4 carriers. Alzheimers Dement. (Amst.) 2020 12 1 e12110 10.1002/dad2.12110 33015312
    [Google Scholar]
  35. He X Li X Fu J et al The morphometry of left cuneus mediating the genetic regulation on working memory. Hum. Brain Mapp. 2021 42 11 3470 3480 10.1002/hbm.25446 33939221
    [Google Scholar]
  36. Russo AA Khajeh R Bittner SR et al Neural trajectories in the supplementary motor area and motor cortex exhibit distinct geometries, compatible with different classes of computation. Neuron 2020 107 4 745 758.e6 10.1016/j.neuron.2020.05.020 32516573
    [Google Scholar]
  37. Alahmadi A.A.S Beyond boundaries: investigating shared and divergent connectivity in the pre-/postcentral gyri and supplementary motor area. Neuroreport 2024 35 5 283 290 10.1097/WNR.0000000000002011 38407836
    [Google Scholar]
  38. Hertrich I Dietrich S Ackermann H The role of the supplementary motor area for speech and language processing. Neurosci. Biobehav. Rev. 2016 68 602 610 10.1016/j.neubiorev.2016.06.030 27343998
    [Google Scholar]
  39. Ziccardi S Crescenzo F Guandalini M et al Early regional cerebral grey matter damage predicts long-term cognitive impairment phenotypes in multiple sclerosis: a 20-year study. Brain Commun. 2024 6 6 fcae355 10.1093/braincomms/fcae355 39494361
    [Google Scholar]
  40. Pines A.R Cieslak M Larsen B et al Leveraging multi-shell diffusion for studies of brain development in youth and young adulthood. Dev. Cogn. Neurosci. 2020 43 100788 10.1016/j.dcn.2020.100788 32510347
    [Google Scholar]
  41. Lebel C Deoni S The development of brain white matter microstructure. Neuroimage 2018 182 207 218 10.1016/j.neuroimage.2017.12.097 29305910
    [Google Scholar]
  42. Song Y Xu T Chen X et al Brain structural changes in diabetic retinopathy patients: A combined voxel-based morphometry and surface-based morphometry study. Brain Imaging Behav. 2024 18 5 1131 1143 10.1007/s11682‑024‑00905‑7 39172355
    [Google Scholar]
  43. Raud L Sneve M.H Vidal-Piñeiro D et al Hippocampal-cortical functional connectivity during memory encoding and retrieval. Neuroimage 2023 279 120309 10.1016/j.neuroimage.2023.120309 37544416
    [Google Scholar]
  44. Wiesman A.I Mundorf V.M Casagrande C.C et al Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer’s disease spectrum. EBioMedicine 2021 73 103638 10.1016/j.ebiom.2021.103638 34689085
    [Google Scholar]
  45. Shine J.M Lewis L.D Garrett D.D Hwang K The impact of the human thalamus on brain-wide information processing. Nat. Rev. Neurosci. 2023 24 7 416 430 10.1038/s41583‑023‑00701‑0 37237103
    [Google Scholar]
  46. Cai L.N Yue J Cao D.N et al Structural and functional activities of brain in patients with vascular cognitive impairment: A case-controlled magnetic resonance imaging study. Medicine 2023 102 15 e33534 10.1097/MD.0000000000033534 37058059
    [Google Scholar]
  47. Ding W Cao W Wang Y et al Altered functional connectivity in patients with subcortical vascular cognitive impairment-A resting-state functional magnetic resonance imaging study. PLoS One 2015 10 9 e0138180 10.1371/journal.pone.0138180 26376180
    [Google Scholar]
  48. He M Li Y Zhou L et al Relationships between memory impairments and hippocampal structure in patients with subcortical ischemic vascular disease. Front. Aging Neurosci. 2022 14 823535 10.3389/fnagi.2022.823535 35517055
    [Google Scholar]
  49. Wang L Ma Q Clinical benefits and pharmacology of scutellarin: A comprehensive review. Pharmacol. Ther. 2018 190 105 127 10.1016/j.pharmthera.2018.05.006 29742480
    [Google Scholar]
  50. Lee R Kim JH Kim WW et al Emerging evidence that ginseng components improve cognition in subjective memory impairment, mild cognitive impairment, and early Alzheimer’s disease dementia. J. Ginseng Res. 2024 48 3 245 252 10.1016/j.jgr.2024.02.002 38707644
    [Google Scholar]
  51. Zhao Y Yang S Guo Q Guo Y Zheng Y Ji E Shashen-Maidong Decoction improved chronic intermittent hypoxia-induced cognitive impairment through regulating glutamatergic signaling pathway. J. Ethnopharmacol. 2021 274 114040 10.1016/j.jep.2021.114040 33794336
    [Google Scholar]
  52. Xing N.N Qu H.D Ren W.C Research progress on main chemical constituents and modern pharmacological effects of Schisandra chinensis. Zhongguo Shiyan Fangjixue Zazhi 2021 27 15 210 218
    [Google Scholar]
  53. Zhao K Li Z Sun T et al Editorial: Novel therapeutic target and drug discovery for neurological diseases, volume II. Front. Pharmacol. 2025 16 1566950 10.3389/fphar.2025.1566950 40083374
    [Google Scholar]
/content/journals/car/10.2174/0115672050405934250902112132
Loading
Clinical Study on the Neuroprotective Effects of Dengzhan Shengmai Capsule on Brain Structure and Cognitive Function in Patients with Vascular Cognitive Impairment
Bentham Science Publishers ; https://doi.org/10.2174/0115672050405934250902112132
/content/journals/car/10.2174/0115672050405934250902112132
/content/journals/car/10.2174/0115672050405934250902112132
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher’s web site along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: Vascular cognitive impairment ; dementia ; cognitive ability ; brain structure ; Dengzhan Shengmai capsule ; traditional Chinese medicine

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test